We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome.
- Authors
Carey, Lisa A; Metzger, Richard; Dees, E Claire; Collichio, Frances; Sartor, Carolyn I; Ollila, David W; Klauber-DeMore, Nancy; Halle, Jan; Sawyer, Lynda; Moore, Dominic T; Graham, Mark L
- Abstract
Response to neoadjuvant chemotherapy is used as an intermediate endpoint for breast cancer relapse and survival. Most breast cancer response classification systems use pathologic complete response, either alone or in conjunction with clinical assessments, to categorize response. We examined the ability of the revised 2003 American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging system, which considers both the number of involved axillary lymph nodes and the extent of tumor in the breast to predict patient survival after neoadjuvant chemotherapy for breast cancer.
- Publication
Journal of the National Cancer Institute, 2005, Vol 97, Issue 15, p1137
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/dji206